Print this page    •   Back to Web version of article

Fixed-Dose Combination Efavirenz/Tenofovir/FTC for South Africa

By Polly Clayden

May/June 2013

After a considerable wait (and considerable campaigning), in 2012, the South African Minister of Health, announced the award of a new antiretroviral tender -- worth R5.9 billion (£406,226,800).

For the first time since the ART program began, the tender includes a triple fixed-dose combination (FDC). The FDC is efavirenz/tenofovir/FTC for first line treatment and it is anticipated that over 90% of new patients will be eligible to initiate this FDC, including pregnant women.


The Southern African Clinicians Society advice document. Fixed-dose combination for adults accessing antiretroviral therapy. SAHIVMED Vol 14, No 1 (2013).

Links to other websites are current at date of posting but not maintained.

This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.